vs

Side-by-side financial comparison of Blue Hat Interactive Entertainment Technology (BHAT) and Cellectis S.A. (CLLS). Click either name above to swap in a different company.

Blue Hat Interactive Entertainment Technology is the larger business by last-quarter revenue ($13.1M vs $9.5M, roughly 1.4× Cellectis S.A.). Blue Hat Interactive Entertainment Technology runs the higher net margin — -9.9% vs -265.9%, a 256.0% gap on every dollar of revenue.

Blue Hat Interactive Entertainment Technology develops and produces interactive entertainment products including AR games, smart interactive toys, and immersive leisure content. It primarily serves mainland China's consumer market, with expanding distribution across Southeast Asia, focusing on family and youth entertainment segments.

Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.

BHAT vs CLLS — Head-to-Head

Bigger by revenue
BHAT
BHAT
1.4× larger
BHAT
$13.1M
$9.5M
CLLS
Higher net margin
BHAT
BHAT
256.0% more per $
BHAT
-9.9%
-265.9%
CLLS

Income Statement — Q2 FY2025 vs Q2 FY2024

Metric
BHAT
BHAT
CLLS
CLLS
Revenue
$13.1M
$9.5M
Net Profit
$-1.3M
$-25.3M
Gross Margin
8.3%
Operating Margin
-9.4%
-181.1%
Net Margin
-9.9%
-265.9%
Revenue YoY
375.0%
Net Profit YoY
-51.9%
EPS (diluted)
$-0.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BHAT
BHAT
CLLS
CLLS
Q2 25
$13.1M
Q2 24
$46.3M
$9.5M
Q3 23
$1.6M
Q2 23
$2.0M
Q2 22
$2.7M
Net Profit
BHAT
BHAT
CLLS
CLLS
Q2 25
$-1.3M
Q2 24
$-4.4M
$-25.3M
Q3 23
$-17.5M
Q2 23
$-16.6M
Q2 22
$-19.5M
Gross Margin
BHAT
BHAT
CLLS
CLLS
Q2 25
8.3%
Q2 24
0.2%
Q3 23
Q2 23
97.3%
Q2 22
87.9%
Operating Margin
BHAT
BHAT
CLLS
CLLS
Q2 25
-9.4%
Q2 24
-8.8%
-181.1%
Q3 23
-1258.1%
Q2 23
-1180.5%
Q2 22
-1003.0%
Net Margin
BHAT
BHAT
CLLS
CLLS
Q2 25
-9.9%
Q2 24
-9.4%
-265.9%
Q3 23
-1064.1%
Q2 23
-831.6%
Q2 22
-714.4%
EPS (diluted)
BHAT
BHAT
CLLS
CLLS
Q2 25
Q2 24
$-0.28
Q3 23
$-0.31
Q2 23
$-0.20
Q2 22
$-0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BHAT
BHAT
CLLS
CLLS
Cash + ST InvestmentsLiquidity on hand
$14.3K
$149.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$32.1M
$148.6M
Total Assets
$75.2M
$407.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BHAT
BHAT
CLLS
CLLS
Q2 25
$14.3K
Q2 24
$407.6K
$149.0M
Q3 23
Q2 23
$84.4M
Q2 22
$129.4M
Stockholders' Equity
BHAT
BHAT
CLLS
CLLS
Q2 25
$32.1M
Q2 24
$40.6M
$148.6M
Q3 23
$76.1M
Q2 23
$96.6M
Q2 22
$180.5M
Total Assets
BHAT
BHAT
CLLS
CLLS
Q2 25
$75.2M
Q2 24
$49.3M
$407.1M
Q3 23
$209.7M
Q2 23
$227.7M
Q2 22
$320.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BHAT
BHAT
CLLS
CLLS
Operating Cash FlowLast quarter
$2.6M
$28.9M
Free Cash FlowOCF − Capex
$27.6M
FCF MarginFCF / Revenue
290.5%
Capex IntensityCapex / Revenue
13.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BHAT
BHAT
CLLS
CLLS
Q2 25
$2.6M
Q2 24
$28.9M
Q3 23
Q2 23
$-47.4M
Q2 22
$-60.2M
Free Cash Flow
BHAT
BHAT
CLLS
CLLS
Q2 25
Q2 24
$27.6M
Q3 23
Q2 23
$-47.9M
Q2 22
$-61.7M
FCF Margin
BHAT
BHAT
CLLS
CLLS
Q2 25
Q2 24
290.5%
Q3 23
Q2 23
-2391.4%
Q2 22
-2266.7%
Capex Intensity
BHAT
BHAT
CLLS
CLLS
Q2 25
Q2 24
13.2%
Q3 23
Q2 23
24.1%
Q2 22
56.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons